e-SPACE Heart Failure 2024
Published: 28 October 2024
-
Views:
165
-
Likes:
7
-
Views:
165
-
Likes:
7
-
Up Next -
1h 2m 9sPart 1 | Session 2 Plenary session 2 – SGLT2s in clinical practice
-
1h 7m 6s
-
59m 29sPart 1 | Session 4 Plenary session 3 – Obesity and weight management in HF
-
28m 30sPart 1 | Session 5 Special session 2 – Face to face with cardiac amyloidosis
-
1h 10m 15sPart 1 | Session 6 Plenary session 4 – Managing cardiomyopathy in HF
-
1h 4m 48sPart 1 | Session 7 Plenary session 5 – Cardiac rhythm in HF
-
1h 13m 18sPart 1 | Session 8 Plenary session 6 – Devices in HF; time to reassess their place?
-
58m 32sPart 2 | Session 1 Plenary session 7 – Enabling GDMT in HF
-
1h 54sPart 2 | Session 2 Plenary session 8 – Iron deficiency: the totality of evidence
-
59m 41sPart 2 | Session 3 Plenary session 9 – Managing HFpEF in 2024
-
1h 45sPart 2 | Session 4 Plenary session 10 – Valvular heart disease
-
59m 47s
Overview
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure held on the 18-19 October 2024.
e-SPACE Heart Failure 2024 once again provided top-tier free virtual education and optimised geographical reach whilst delivering both global and regional insight. The thoughtfully curated programme explored how leading experts are incorporating heart failure guidelines into clinical practice and offered the latest information on patient profiling in heart failure for tailored medical therapy.
Building on the tremendous success of previous years, this event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Related sessions to e-SPACE Heart Failure 2024:
- Meet the Experts: SGLT2 Inhibitors in Real Life: Everything the Clinician Needs to Know
- Meet the Experts: GDMT Implementation in HF: How to Tackle Clinical Inertia?
- Meet the Experts: Management of Transthyretin Amyloid Cardiomyopathy (ATTRCM): Optimising Patient Pathways
- Meet the Experts: IV Iron in Clinical Practice: Experts’ Perspectives
- Meet the Experts: Hyperkalemia in HF: Clinical Impact and Long-term Management
- Symposium: SGLT2 Inhibitors in Heart Failure: Updates on Prevention and Treatment
- Meet the Experts: Non-steroidal MRAs: Evolving Role in Heart Failure
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Vijay Chopra
Senior Director of Clinical Cardiology, Heart Failure and Research
Dr Vijay Chopra is the Senior Director of Clinical Cardiology, Heart Failure and Research in the Heart Failure Programme at the Max Super Specialty Hospital in Saket, New Delhi, India. He is considered a pioneer in preventive cardiology, and has worked extensively in the management of patients with advanced heart disease. He has been principal investigator of numerous international clinical trials.
Dr Chopra's research interests include preventive cardiology, heart failures and advanced heart diseases. He was awarded the Kutumbiah Prize in Clinical Medicine from CMC Vellore in 1972. He founded the Heart Failure Association of India (HFAI), and served as its first president from 2014 - 2019.
Dr Chopra has over 50 publications in peer-reviewed journals.
Dr Vijay Chopra is an Editorial Board member of Cardiac Failure Review and may be contacted
Tarek Bekfani
Consultant Cardiologist
Dr Tarek Bekfani is a Consultant Cardiologist at University hospital Magdeburg A.o.R., Magdeburg, DE.
Gianluigi Savarese
Associate Professor of Cardiology
Prof Gianluigi Savarese is currently an Associate Professor of Cardiology and Heart Failure Specialist at the Karolinska Institute in Stockholm, Sweden.
Prof Savarese has served on the board for the European Society of Cardiology's Heart Failure Association since 2020, and has previously been a Nucleus member of a working group on Cardiovascular Pharmacotherapy for the ESC. He is a member of the Italian Society of Cardiology, and the Swedish Society of Cardiology.
Prof Savarese attended the University of Naples Federico II University for his degree in Surgery and Medicine between 2004 - 2010. He then went on to stay at the same institution until 2016 as he completed his Specialism in Cardiovascular Diseases. He then continued his postgraduate studies at the University of Zurich between 2015-2017, where he continued his studies into Heart Failure. Finally, Prof Savarese completed his PhD at the Karolinska Institutet in 2018.
Prof Savarese has…
Jasper J Brugts
Heart Failure Cardiologist
Dr Jasper J Brugts is a Heart Failure Cardiologist at Erasmus University Medical Centre, Rotterdam, NL.
He is also a clinical epidemiologist and clinical trialist.
Justin Ezekowitz
Dr. Ezekowitz, an accomplished professional in the field of cardiology, serves as the co-director of the Canadian VIGOUR Centre at the University of Alberta. He has spearheaded the establishment of five new heart failure clinics across Alberta to enhance access to specialized services. Furthermore, he plays a pivotal role in co-chairing the heart failure care pathway initiative as part of Alberta Health Services Strategic Clinical Networks.
Dr. Ezekowitz's clinical focus centers on cardiology, with a primary emphasis on heart failure. He practices at the Mazankowski Alberta Heart Institute, where he contributes to the Heart Function Clinic.
In the realm of research, Dr. Ezekowitz dedicates his efforts to acute and chronic heart failure, particularly in individuals with heart "pump" issues or end-stage heart disease. He actively engages in numerous local and international clinical trials aimed at identifying novel treatments and care strategies for heart failure…